| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.086 | 0.09 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |